Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of those who did not respond to the latest cancer treatments, known as immune ...

Mitochondrial DNA emerges as a key factor in melanoma checkpoint inhibitor resistance, revealing new potential biomarker for patients.

Dr. Aditya Bansal University of Kentucky When you think of cancer, eye cancer may not be the first thing that comes to mind.

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...

A combination of BRAF and MEK inhibitors plus immunotherapy improved progression-free but not overall survival, compared to dual immune checkpoint blockade.

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Encorafenib and binimetinib show promise in reducing recurrence risk for high-risk BRAF V600-mutant melanoma, demonstrating a ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Combination treatment could also benefit patients with lung, bowel, pancreatic and other solid cancers who don’t respond to ...

Learn critical nail changes that could indicate melanoma. Discover how to inspect your nails for deadly skin cancer signs that often go unnoticed by most people ...

Emerging research is uncovering how a fiber-rich, whole-foods-based diet may help support better outcomes for patients ...